CD8A and neoplasm: L-NAME combined with GalCer significantly increased the tumor antigen-specific response of mice with lung metastasis, increased the proportion of CD8+ T cells in the bronchoalveolar lavage fluid, and increased the antitumor effect of GalCer in a model of lung metastasis [145].